Delayed skin wound repair in proline-rich protein tyrosine kinase 2 knockout mice

Am J Physiol Cell Physiol. 2014 May 15;306(10):C899-909. doi: 10.1152/ajpcell.00331.2013. Epub 2014 Mar 5.

Abstract

Proline-rich protein tyrosine kinase 2 (Pyk2) is a member of the focal adhesion kinase family. We used Pyk2 knockout (Pyk2-KO) mice to study the role of Pyk2 in cutaneous wound repair. We report that the rate of wound closure was delayed in Pyk2-KO compared with control mice. To examine whether impaired wound healing of Pyk2-KO mice was caused by a keratinocyte cell-autonomous defect, the capacities of primary keratinocytes from Pyk2-KO and wild-type (WT) littermates to heal scratch wounds in vitro were compared. The rate of scratch wound repair was decreased in Pyk2-KO keratinocytes compared with WT cells. Moreover, cultured human epidermal keratinocytes overexpressing the dominant-negative mutant of Pyk2 failed to heal scratch wounds. Conversely, stimulation of Pyk2-dependent signaling via WT Pyk2 overexpression induced accelerated scratch wound closure and was associated with increased expression of matrix metalloproteinase (MMP)-1, MMP-9, and MMP-10. The Pyk2-stimulated increase in the rate of scratch wound repair was abolished by coexpression of the dominant-negative mutant of PKCδ and by GM-6001, a broad-spectrum inhibitor of MMP activity. These results suggest that Pyk2 is essential for skin wound reepithelialization in vivo and in vitro and that it regulates epidermal keratinocyte migration via a pathway that requires PKCδ and MMP functions.

Keywords: epidermis; knockout mice; nonreceptor tyrosine kinase; proline-rich protein tyrosine kinase 2; wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Movement / drug effects
  • Cells, Cultured
  • Dipeptides / pharmacology
  • Focal Adhesion Kinase 2 / deficiency
  • Focal Adhesion Kinase 2 / genetics*
  • Gene Expression Regulation
  • Genes, Dominant
  • Humans
  • Keratinocytes / cytology
  • Keratinocytes / drug effects
  • Keratinocytes / metabolism*
  • Male
  • Matrix Metalloproteinase 1 / genetics
  • Matrix Metalloproteinase 1 / metabolism
  • Matrix Metalloproteinase 10 / genetics
  • Matrix Metalloproteinase 10 / metabolism
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / metabolism
  • Matrix Metalloproteinase Inhibitors / pharmacology
  • Mice
  • Mice, Knockout
  • Protein Kinase C-delta / genetics
  • Protein Kinase C-delta / metabolism*
  • Re-Epithelialization / genetics*
  • Signal Transduction
  • Skin / drug effects
  • Skin / injuries
  • Skin / metabolism*

Substances

  • Dipeptides
  • Matrix Metalloproteinase Inhibitors
  • N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide
  • Focal Adhesion Kinase 2
  • Ptk2b protein, mouse
  • Protein Kinase C-delta
  • Matrix Metalloproteinase 10
  • Matrix Metalloproteinase 9
  • Matrix Metalloproteinase 1